Daniel Bensen

Chief Operating Officer

Daniel Bensen (Chief Operating Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales, 1 filed past the two-business-day deadline), most often in TYRA. The largest single filing was $2.1M of TYRA (128,800 sh across 2 lots, as filed), executed Nov 14 2025. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells · 1 late

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$576K

shares × price, as filed

Last traded

Feb 12

Filed Feb 13

Open performance→

Volume by month

Buys $0 Sells $4.7M

Shares × price, as filed · by filing month · past 24 months

Most traded names

TYRA TYRA 0 buys · 5 sells 5 filings

Recent filings

TYRASALE Tyra Biosciences, Inc. View filing → $196K
5,872 sh × $33.37
Exec Feb 12
Filed Feb 13 · 5:30 PM ET TYRASALE Tyra Biosciences, Inc. View filing → $199K
6,983 sh × $28.44
Exec Jan 12
Filed Jan 20 · 5:30 PM ET † TYRASALE Tyra Biosciences, Inc. View filing → $181K
8,000 sh × $22.64
Exec Dec 12 2025
Filed Dec 16 2025 · 5:30 PM ET TYRASALE Tyra Biosciences, Inc. View filing → $2.0M
125,589 sh across 2 lots
Exec Nov 18 2025
Filed Nov 19 2025 · 5:30 PM ET TYRASALE Tyra Biosciences, Inc. View filing → $2.1M
128,800 sh across 2 lots
Exec Nov 14 2025
Filed Nov 17 2025 · 5:30 PM ET